There are 140 resources available
64P - Response to PARPi in advanced high-grade serous ovarian cancer (HGSOC) based on the location and type of BRCA mutation: Real-world data from a Spanish tertiary university hospital
Presenter: Isabel Miras Rodriguez
Session: Poster Display
65P - Chemotherapy response score (CRS) and efficacy of PARP inhibitor (PARPi) treatment in advanced epithelial ovarian cancer (AEOC)
Presenter: Patricia Pérez de Aguado
Session: Poster Display
66P - PARPi and myeloid neoplasia: The Italian MITO-MaNGO experience based on a multicentric survey
Presenter: margherita turinetto
Session: Poster Display
67P - Factors that may influence physicians’ perceptions of “cure” in ovarian cancer: A discrete choice experiment
Presenter: Robert Coleman
Session: Poster Display
68P - The effectiveness of treatment of ascites due to recurrence of platinum-refractory ovarian cancer using metronomic chemotherapy
Presenter: Shaxnoza Shaxanova
Session: Poster Display
70P - Tumor biomarkers contribute to the clinical management of the O-RADS MRI risk stratification system in epithelial ovarian tumors
Presenter: Shengjie Xu
Session: Poster Display
72P - Real-world data of treatment and outcome of patients with advanced ovarian cancer (AOC) in Germany: QS OVAR of the AGO Study Group
Presenter: Philipp Harter
Session: Poster Display
77P - The association between chlamydia trachomatis infection and epithelial ovarian cancer risk using mendelian randomisation
Presenter: Sarah Perrott
Session: Poster Display
78P - Age-adjusted trends of malignant ovarian granulosa cell tumor
Presenter: Dina Hassan
Session: Poster Display